ARE

Alexandria Real Estate Equities Inc

Exchange: NYSESector: Real EstateIndustry: REIT - Office

Alexandria Real Estate Equities, Inc., an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of $20.75 billion and an asset base in North America that includes 35.9 million RSF of operating properties. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Current Price

$47.85

+0.02%

Profile

Valuation (TTM)

Market Cap$8.29B

P/E-7.77

EV$20.17B

P/B0.54

Shares Out173.30M

P/Sales2.82

Revenue$2.94B

EV/EBITDA41.17

Alexandria Real Estate Equities Inc (ARE) Company Profile

GoodMoat Analysis

Based on data as of March 26, 2026

Alexandria Real Estate Equities Inc is a specialized REIT focused on leasing lab and office space to life science and technology tenants. While its focus on a niche, mission-critical real estate segment provides a potential moat, the company currently faces severe financial distress, including significant losses, negative revenue growth, and a high dividend yield that may be unsustainable.

Read full analysis

Alexandria Real Estate Equities Inc (ARE) is a Real Estate Investment Trust (REIT) that owns, operates, and develops highly specialized properties for life science and technology companies. Its core business is leasing laboratory and office space to tenants like biotech firms, pharmaceutical companies, and tech research teams. These customers require specific, complex infrastructure (e.g., high-power capacity, specialized ventilation) that standard offices cannot provide, making ARE's properties mission-critical for their operations. This specialization is the foundation of its potential competitive advantage, or moat. According to the GoodMoat framework, this aligns with 'Niche Dominance' (criterion #10), where a company is a dominant, mission-critical provider in a specialized market that is unattractive for generalist competitors to enter. However, applying the framework reveals significant red flags. The company's financial data shows a Profit Margin of -47.2%, an ROE of -9.2%, and YoY Revenue Growth of -5.2%, indicating severe operational challenges. These metrics directly trigger the 'Margin Compression' and 'Execution Risk' High Confidence Red Flags from Section 5. Furthermore, a Dividend Yield of 11.15% is exceptionally high and, when paired with negative earnings, raises serious questions about its sustainability, pointing to potential cash flow issues. For a value investor, the extreme negative valuation multiples (like a P/E of -5.7) and high FCF Yield of 22.8% might initially seem attractive, but they are symptoms of deep fundamental problems. The investment case hinges on whether the company's niche moat is durable enough to allow a financial recovery, which is currently overshadowed by the prominent red flags in its financial health.

ARE Company Information

Alexandria Real Estate Equities, Inc. , an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.

With our founding in 1994, Alexandria pioneered the life science real estate niche.

Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus™ ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.

As of December 31, 2025, Alexandria has a total market capitalization of $20. 75 billion and an asset base in North America that includes 35. 9 million RSF of operating properties.

Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success.

Alexandria also provides strategic capital to transformative life science companies through our venture capital platform.

We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Sector

Real Estate

Industry

REIT - Office

Exchange

NYSE

Country

California, USA

ARE Key Officers

Key officers data coming soon

ARE Company Profile

Alexandria Real Estate Equities Inc (ARE) is a Real Estate company in the REIT - Office industry. It trades on NYSE. The company is based in California, USA.

Market cap is $8.29B. There are 173.3M shares outstanding. Dividend yield is 10.99%.

See the full Alexandria Real Estate Equities Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if ARE is a good investment.